TABLE 2.
Interactions described in this study
Nucleoporin | NPC localizationa | Motifb | Resultf
|
||
---|---|---|---|---|---|
HSV-1 capsid IPc | HSV-1 pUL25 IPc | PrV pUL25 yeastd | |||
CAN/Nup214e | Cyto | FG, Gly, CC, BP, LZ, AH | + | + | + |
hNup153 | Nuc | FG, Gly, ZF | NT | NT | − |
hNup133 | Cyto + Nuc | BP, AHR | − | − | NT |
hNup54 | Cyto + Nuc | FG, Gly, CC | − | − | NT |
hNup50 | Nuc | FG, RBD | − | − | NT |
hCG1 | Cyto | FG, ZF, CC | − | + | +g |
POM121 | PM | FG, Gly, TM | NT | NT | − |
Nup98 | Nuc | FG, Gly | NT | NT | − |
Cyto, cytoplasmic face; Nuc, nucleoplasmic face; PM, pore membrane (11).
FG, FG repeats; Gly, glycosylated; RBD, Ran-binding domain; ZF, zinc fingers; CC, coiled coil; LZ, leucine zipper; AH, amphipathic helix; BD, β-propeller; TM, transmembrane helix.
See Table 3 for details.
NT, not tested.
Only amino acids 1 to 380 (see Table 3 for details).